Measurement of low (sub-therapeutic) phenobarbitone levels in plasma by high-performance liquid chromatography: application to patient compliance studies

This publication has 9 references indexed in Scilit:

• Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily
  Clinical Pharmacology & Therapeutics, 1988
• Use of a pharmacological indicator to monitor compliance with thyroxine
  European Journal of Clinical Pharmacology, 1988
• Low‐dose phenobarbitone as an indicator of compliance with drug therapy.
  British Journal of Clinical Pharmacology, 1987
• Simultaneous measurement of phenobarbital, carbamazepine, phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in serum by high-performance liquid chromatography
  The Analyst, 1987
• The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
  British Journal of Clinical Pharmacology, 1986
• Correlation between fluorescent polarisation immunoassay and enzyme immunoassay of anticonvulsant drugs, and stability of calibration graphs
  The Analyst, 1986
• Analysis of barbiturates in plasma and urine using gas chromatography without prior derivatization
  Journal of Chromatography A, 1983
• Antiepileptic Drug Monitoring by Chromatographic Methods and Immunotechniques—Comparison of Analytical Performance, Practicability, and Economy
  Therapeutic Drug Monitoring, 1983
• Analysis of barbiturates in blood by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981